Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (66.7%)
N/A1 (33.3%)

Trials by Status

completed360%
terminated120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
terminatednot_applicable

Bone Mineral Density (BMD) in HIV Infection

NCT00146094
completedphase_2

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

NCT03041012
completed

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

NCT03205696
recruitingphase_2

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

NCT06676410
completed

The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)

NCT03049176

Clinical Trials (5)

Showing 5 of 5 trials
NCT00146094Not Applicable

Bone Mineral Density (BMD) in HIV Infection

Terminated
NCT03041012Phase 2

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Completed
NCT03205696

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection

Completed
NCT06676410Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants

Recruiting
NCT03049176

The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5